New Nordic Healthbrands AB (publ)
New Nordic Healthbrands AB (publ) develops and markets dietary supplements, herbal pharmaceutical, and personal care products in the Nordic countries, rest of Europe, North America, and internationally. The company provides vitality tablets, capsules, and gummy products, including vitamins and minerals, fish oil and Omega-3, and magnesium, as well as for body, sleep and relaxation, menopause, and… Read more
New Nordic Healthbrands AB (publ) (NNH) - Total Liabilities
Latest total liabilities as of September 2025: Skr152.78 Million SEK
Based on the latest financial reports, New Nordic Healthbrands AB (publ) (NNH) has total liabilities worth Skr152.78 Million SEK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
New Nordic Healthbrands AB (publ) - Total Liabilities Trend (2008–2024)
This chart illustrates how New Nordic Healthbrands AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
New Nordic Healthbrands AB (publ) Competitors by Total Liabilities
The table below lists competitors of New Nordic Healthbrands AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Madhucon Projects Limited
NSE:MADHUCON
|
India | ₹56.54 Billion |
|
Master Drilling Group Ltd
JSE:MDI
|
South Africa | ZAC176.82 Million |
|
IPB Petroleum Ltd
AU:IPB
|
Australia | AU$57.33K |
|
Fitness Champs Holdings Limited Common Stock
NASDAQ:FCHL
|
USA | $2.35 Million |
|
Slam Exploration Ltd
PINK:SLMXF
|
USA | $619.58K |
|
Zynex Inc
NASDAQ:ZYXI
|
USA | $86.69 Million |
|
SWISS RE N (SR9.SG)
STU:SR9
|
Germany | €163.21 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down New Nordic Healthbrands AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.08 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how New Nordic Healthbrands AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for New Nordic Healthbrands AB (publ) (2008–2024)
The table below shows the annual total liabilities of New Nordic Healthbrands AB (publ) from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr148.19 Million | +3.61% |
| 2023-12-31 | Skr143.03 Million | +2.82% |
| 2022-12-31 | Skr139.10 Million | +17.85% |
| 2021-12-31 | Skr118.03 Million | +36.17% |
| 2020-12-31 | Skr86.68 Million | -9.01% |
| 2019-12-31 | Skr95.27 Million | +15.57% |
| 2018-12-31 | Skr82.43 Million | +5.67% |
| 2017-12-31 | Skr78.01 Million | -7.81% |
| 2016-12-31 | Skr84.61 Million | -5.42% |
| 2015-12-31 | Skr89.46 Million | +18.33% |
| 2014-12-31 | Skr75.60 Million | -1.48% |
| 2013-12-31 | Skr76.74 Million | -7.83% |
| 2012-12-31 | Skr83.25 Million | +0.38% |
| 2011-12-31 | Skr82.94 Million | -9.34% |
| 2010-12-31 | Skr91.48 Million | -16.94% |
| 2009-12-31 | Skr110.14 Million | -10.21% |
| 2008-12-31 | Skr122.67 Million | -- |